PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaAll Plans · Coverage · Medical Policy · ENT (Ear, Nose & Throat), PediatricsMedium impact

Myringotomy and Tympanostomy Tube (CPB 0418, reviewed 2026-06-30)

Effective date
Not stated in the notice
Identified
Aug 17, 2026

Summary

Aetna considers myringotomy and tympanostomy tube insertion medically necessary for cholesteatoma, chronic retraction of the tympanic membrane or pars flaccida, complications of otitis media such as meningitis, facial nerve paralysis, coalescent mastoiditis or brain abscess, and severe otalgia in acute otitis media. Tympanostomy tube insertion is medically necessary for otitis media with effusion lasting 3 months or longer with bilateral hearing impairment of 20 dB or worse in both ears, and for recurrent acute otitis media with more than 3 episodes in 6 months or more than 4 episodes in 12 months. Tympanostomy tube insertion is not medically necessary for a single episode of otitis media with effusion lasting less than 3 months, or for recurrent acute otitis media in children who have no middle ear effusion in either ear at the time of assessment for tube candidacy. Balloon dilation of the Eustachian tube is medically necessary for individuals 8 to 17 years of age, and for adults with chronic Eustachian tube dysfunction, when the listed criteria are met. Shim placement in the Eustachian tube is medically necessary for a patulous Eustachian tube. OtoScan laser-assisted myringotomy is considered as effective as traditional myringotomy, and the same selection criteria apply to both. Myringotomy and tympanostomy tube insertion for all other indications, soft-tissue fillers for a patulous Eustachian tube, phosphorylcholine-coated and vancomycin-coated tympanostomy tubes, the EarPopper device, balloon dilation of the Eustachian tube after an initially successful or unsuccessful balloon dilation, with tympanoplasty or other middle ear surgery, or for chronic ear disease, the Tubes Under Local Anesthesia (Tula) System, and the Hummingbird Tympanostomy Tube System are considered experimental, investigational or unproven.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 4 steps
01Billing team: Bill CPT 69420, 69421, 69424, 69433 and 69436 only when the selection criteria in the policy are met, because these codes are covered only in that case.
02Bill CPT 69705 and 69706 for balloon dilation of the Eustachian tube only when its criteria are met, including the age 8 to 17 criteria or the adult criteria.
03Do not bill CPT 0583T, HCPCS C1878 or HCPCS G0561 for the indications the policy lists as not covered.
04Do not bill the EarPopper device, trans-tympanic balloon dilatation of the Eustachian tube, the Tula System or the Hummingbird Tympanostomy Tube System as covered for the uses the policy lists as experimental, investigational or unproven.

Codes mentioned

69420694216942469433694366970569706G0561C1878C41.0D33.3D35.2D44.3D44.4E23.6

Original notice

Myringotomy and Tympanostomy Tube (CPB 0418, reviewed 2026-06-30)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account